Improving sleep treatment for people with opioid use disorder
Health equity informed delivery of cognitive behavioral therapy for insomnia adapted for individuals with opioid use disorder
This study is looking at a special type of therapy to help adults with opioid use disorder who also have trouble sleeping, aiming to make sure the treatment works well for everyone and supports their recovery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-11084542 on NIH RePORTER |
What this research studies
This research focuses on developing and testing a tailored approach to Cognitive Behavioral Therapy for Insomnia (CBT-I) specifically for adults struggling with opioid use disorder (OUD). It aims to address the high prevalence of insomnia among this population, which can hinder their recovery and increase overdose risks. By integrating health equity principles, the study seeks to ensure that the treatment is accessible and effective for diverse groups affected by OUD. Participants will receive a refined CBT-I intervention designed to meet their unique biopsychosocial needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are currently receiving treatment for opioid use disorder and experiencing insomnia.
Not a fit: Patients who do not have opioid use disorder or those who do not experience insomnia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve sleep quality and recovery outcomes for individuals with opioid use disorder.
How similar studies have performed: Previous research has shown that tailored behavioral therapies can enhance treatment effectiveness for individuals with opioid use disorder, indicating potential for success in this novel approach.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Martin, Caitlin Eileen — Virginia Commonwealth University
- Study coordinator: Martin, Caitlin Eileen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.